SUMMARY This report deals with the question of whether or not the established association of HLA-DR4 with rheumatoid arthritis (RA) can also be detected in cases of RA as diagnosed in a population survey. For this purpose 6584 persons older than 19 years living in a single community in The Netherlands were investigated for the presence of rheumatoid arthritis and related abnormalities. After five years 83 patients with RA, 30 with only erosive abnormalities on radiological examination (Rad), and 48 with only rheumatoid factor (RF) were reinvestigated and typed for HLA and allotypes of immunoglobulin G heavy chain (GM). On the classification of the initial survey no significant association of HLA-DR4 or GM could be detected in any of the three categories. When the information of the follow-up investigation was taken into account, a reappraisal of the classification resulted in 53 cases with RA, 18 with Rad only, and 35 with RF only. The frequencies of HLA-DR4 and GM in the three categories were also about the same as those in normal controls. However, an increase in the frequency of HLA-DR4 was observed in cases of RA positive for Rad, RF, or both. We found no evidence for an interaction between HLA-DR4 and GM. Our results suggest that rheumatoid arthritis is a heterogeneous disorder, only a fraction of which is associated with HLA-DR4. At present no single determinant of RA such as Rad or RF can characterise the HLA-DR4-associated, and most probably more severe, type of RA.
It is now well established that rheumatoid arthritis (RA) is associated with an increase in frequency of the antigen HLA-DR4 of the human major histocompatibility complex (MHC). [1] [2] [3] However, the mechanism of that association is not known. One of the problems in studying the genetic factors in RA is that RA represents a clinical diagnosis of a disorder with different environmental and genetic components. 4 To determine the relationship of HLA-DR4 and disease susceptibility for RA several investigators have tried to restrict their studies to subgroups of RA. The frequency of HLA-DR4 is higher among severe and progressive RA than among the milder and stable forms of RA.s However, two studies could not detect an association between HLA-DR4 and severity of RA. 3 6 The presence of rheumatoid factor (RF) in RA ('seropositive RA') is associated with an increase of HLA-DR4 in some studies1 7 but not in others.8 9 The observation of an association between HLA-DR4 and RF in RA has been the basis for the hypothesis that HLA-DR4 is primarily associated with the synthesis of anti-immunoglobulin antibodies.10 However, HLA-DR4 was not associated with the presence of rheumatoid factor in healthy women. Other genetic factors have been studied in RA, and one study reported an association between RF in RA and GM, a set of allotypic markers of the immunoglobulin G heavy chains.12
The difficulty of relating HLA-DR4 to subgroups of RA in relation to the clinical course of the disease or the presence of RF, is that seropositive RA is in itself associated with the more severe form of the disease.'3 14 In addition, most of these studies refer to cases of RA collected from hospital records. This introduces a selection of cases with RA, since many of the less severe cases will not come to the attention of the hospital physician. The result of this selection is difficult to estimate, because little is known about the immunogenetic factors involved in RA The clinical and laboratory investigations were the same as in 1975-8, with the addition of typing for HLA and GM. The two doctors performing the clinical investigations also participated in the first investigation. In both studies the clinical classification was primarily according to the Manchester grading, without knowledge of the status of the respondent and without information on serology and radiology.
HLA and GM typing. HLA-A, -B, -C antigens were determined with the standard microcytoxicity assay22 on lymphocytes isolated from heparinised blood samples. Typing for HLA-DR anti'ens was done with the two-colour fluorescence test using a set of 120 allo-antisera. The Gm allotypic markers of immunoglobulin heavy chains were determined with the haemagglutination-inhibition assay. 24 Statistical analysis. Since the definition of RA is based on criteria that fluctuate considerably in time, we restricted the second analysis to those cases that were positive for the criteria of one of the three categories in both the initial population survey and in the follow-up investigation. After the follow-up study was concluded a reappraisal of the material was performed by one of us (H.A.V.). The Common to these criteria is a probability factor, illustrated by categories as 'possible', 'probable', and 'definite'. Shifts of cases among these categories is a well-known observation among rheumatologists. The probability factor a fortiori applies to epidemiological studies, as illustrated by the Sudbury study,?9 because cases with a lower probability for RA are also detected.
In the present study we were able to carry out a five-year follow-up. Finally, the analysis of the GM phenotypes in the various categories revealed no significant associations nor provided evidence for an interaction or association between HLA-DR4 and GM.
Our overall results suggest the following conclusions. The absence of a significance association between HLA-DR4 and RA detected in the population, as compared with the association observed in clinical cases, suggests that RA is a heterogeneous disease. Moreover, the presence of Rad or RF as determinants for RA is not in itself responsible for the association with HLA-DR4. Consequently other and as yet unknown disease factors may be implicated in RA as seen in hospitals. In this regard the presence of HLA-DR4 might be associated with a disease-modifying factor rather than with a disease-susceptibility factor. In agreement with this hypothesis is a recent observation that HLA-DR4 was associated with a more severe disease in seronegative RA, which in itself was not associated with HLA-DR4 (30) . Finally our results suggest that future studies of RA will benefit from an approach that compares, in detail, the HLA-DR4 positive with HLA-DR4 negative cases of RA for various clinical and laboratory parameters. In this regard the severe form of RA, known as the Felty's syndrome, with a strong association of HLA-DR427 might provide a lead to the pathogenetic process involved in HLA-DR4-positive RA. 
